首页> 外国专利> - K Rd Rg3 The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K Rd and Rd3 using -glucosidase and lactic acid bacteria

- K Rd Rg3 The manufacturing method of fermented red ginseng extracts enhanced with ginsenoside compound K Rd and Rd3 using -glucosidase and lactic acid bacteria

机译:-K Rd Rg3-人参皂苷化合物K Rd和Rd3增强的人参皂苷-葡萄糖苷酶和乳酸菌的发酵方法

摘要

The present invention relates to a method for producing a fermented red ginseng concentrate using β-glucosidase and lactic acid bacteria, and more specifically, the red ginseng concentrate is Lactobacillus sakei, Lactobacillus plantarum, Bifidobacterium lactis and Streptococcus thermophil The fermented red ginseng concentrate prepared by culturing with loose is significantly increased in the content of ginsenosides Rg3, Rd and CK, which is easily absorbed by the human body, compared to the existing lactic acid bacteria or fermented red ginseng concentrate made with a fermented strain, the method of the present invention Silver can be usefully used for the production of fermented red ginseng concentrate that is easily absorbed by the body.
机译:本发明涉及一种使用β-葡萄糖苷酶和乳酸菌生产发酵红参浓缩物的方法,更具体地说,该红参浓缩物是清酒乳杆菌,植物乳杆菌,乳酸双歧杆菌和嗜热链球菌。与现有的乳酸菌或由发酵菌株制成的发酵红参浓缩物相比,松散培养的人参皂苷Rg3,Rd和CK的含量明显增加,易于被人体吸收。银可用于生产容易被人体吸收的发酵红参浓缩物。

著录项

  • 公开/公告号KR20200078171A

    专利类型

  • 公开/公告日2020-07-01

    原文格式PDF

  • 申请/专利权人 종근당건강 주식회사;

    申请/专利号KR20180167819

  • 发明设计人 박성선;조경원;김상민;

    申请日2018-12-21

  • 分类号A23L2/385;A23L29;

  • 国家 KR

  • 入库时间 2022-08-21 11:06:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号